Cancer incidence in HIV patients under HAART therapy in a HIV-1 F1 subtype endemic area

1. Centers for Disease, C. (1981). Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb Mortal Wkly Rep, 30(25), 305-308.Search in Google Scholar

2. Haverkos, H. W. & Curran, J. W. (1982). The current outbreak of Kaposi’s sarcoma and opportunistic infections. CA Cancer J Clin, 32(6), 330-339.10.3322/canjclin.32.6.3306812892Search in Google Scholar

3. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. (1987). MMWR Morb Mortal Wkly Rep, 36 Suppl 1, 1s-15s.Search in Google Scholar

4. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. (1992). MMWR Recomm Rep, 41(Rr-17), 1-19.Search in Google Scholar

5. Schneider, E., Whitmore, S., Glynn, K. M., Dominguez, K., Mitsch, A., & McKenna, M. T. (2008). Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep, 57(Rr-10), 1-12.Search in Google Scholar

6. Marconi, V. C., Grandits, G. A., Weintrob, A. C., Chun, H., Landrum, M. L., Ganesan, A., . . . Infectious Disease Clinical Research Program, H. I. V. W. G. (2010). Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study. AIDS Res Ther, 7, 14. doi: 10.1186/1742-6405-7-1410.1186/1742-6405-7-14289473720507622Search in Google Scholar

7. Miailhes, P., Trabaud, M. A., Pradat, P., Lebouche, B., Chevallier, M., Chevallier, P. & Trepo, C. (2007). Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis, 45(5), 624-632. doi: 10.1086/52075210.1086/52075217682999Search in Google Scholar

8. Lloyd-Smith, E., Brodkin, E., Wood, E., Kerr, T., Tyndall, M. W., Montaner, J. S., & Hogg, R. S. (2006). Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS, 20(3), 445-450. doi: 10.1097/01.aids.0000206508.32030.9210.1097/01.aids.0000206508.32030.9216439879Search in Google Scholar

9. Grover, S. A., Coupal, L., Gilmore, N., & Mukherjee, J. (2005). Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy. Am J Cardiol, 95(5), 586-591. doi: 10.1016/j.amjcard.2004.11.00410.1016/j.amjcard.2004.11.00415721096Search in Google Scholar

10. Madeddu, G., Fois, A. G., Calia, G. M., Babudieri, S., Soddu, V., Becciu, F. & Mura, M. S. (2013). Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection, 41(2), 347-353. doi: 10.1007/s15010-012-0330-x10.1007/s15010-012-0330-x22971938Search in Google Scholar

11. Menezes, A. M., Torelly, J., Jr., Real, L., Bay, M., Poeta, J., & Sprinz, E. (2011). Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil. PLoS One, 6(10), e26042. doi: 10.1371/journal.pone.002604210.1371/journal.pone.0026042319215022022501Search in Google Scholar

12. Chen, C. H., Chung, C. Y., Wang, L. H., Lin, C., Lin, H. L., & Lin, H. C. (2015). Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention. BMC Cancer, 15, 133. doi: 10.1186/s12885-015-1099-y10.1186/s12885-015-1099-y436907125885746Search in Google Scholar

13. D’Souza, G., Wiley, D. J., Li, X., Chmiel, J. S., Margolick, J. B., Cranston, R. D., & Jacobson, L. P. (2008). Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr, 48(4), 491-499. doi: 10.1097/QAI.0b013e31817aebfe10.1097/QAI.0b013e31817aebfe399156318614927Search in Google Scholar

14. Hessol, N. A., Pipkin, S., Schwarcz, S., Cress, R. D., Bacchetti, P., & Scheer, S. (2007). The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol, 165(10), 1143-1153. doi: 10.1093/aje/kwm01710.1093/aje/kwm01717344204Search in Google Scholar

15. Louie, J. K., Hsu, L. C., Osmond, D. H., Katz, M. H., & Schwarcz, S. K. (2002). Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis, 186(7), 1023-1027. doi: 10.1086/34386210.1086/343862Search in Google Scholar

16. Smith, C. J., Ryom, L., Weber, R., Morlat, P., Pradier, C., Reiss, P. & Lundgren, J. D. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet, 384(9939), 241-248. doi: 10.1016/s0140-6736(14)60604-810.1016/S0140-6736(14)60604-8Search in Google Scholar

17. Stanojevic, M., Alexiev, I., Beshkov, D., Gokengin, D., Mezei, M., Minarovits, J., . . . Paraskevis, D. (2012). HIV1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity. AIDS Rev, 14(1), 28-36.Search in Google Scholar

18. Paraschiv, S., Otelea, D., Dinu, M., Maxim, D., & Tinischi, M. (2007). Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains. Int J Infect Dis, 11(2), 123-128. doi: 10.1016/j.ijid.2005.11.00610.1016/j.ijid.2005.11.00616762582Search in Google Scholar

19. Paraschiv, S., Foley, B., & Otelea, D. (2011). Diversity of HIV-1 subtype C strains isolated in Romania. Infect Genet Evol, 11(2), 270-275. doi: 10.1016/j.meegid.2010.07.00210.1016/j.meegid.2010.07.00220620240Search in Google Scholar

20. Bandea, C. I., Ramos, A., Pieniazek, D., Pascu, R., Tanuri, A., Schochetman, G., & Rayfield, M. A. (1995). Epidemiologic and evolutionary relationships between Romanian and Brazilian HIV-subtype F strains. Emerg Infect Dis, 1(3), 91-93. doi: 10.3201/eid0103.95030510.3201/eid0103.95030526268808903171Search in Google Scholar

21. Manolescu, L., Temereanca, A., Diaconu, C. C., & Ruta, S. (2011). Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patients. Romanian biotechnological letters, 16(4), 6439-6449.Search in Google Scholar

22. Guimaraes, M. L., Vicente, A. C., Otsuki, K., da Silva, R. F., Francisco, M., da Silva, F. G. & Bello, G. (2009). Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates. Retrovirology, 6, 39. doi: 10.1186/1742-4690-6-3910.1186/1742-4690-6-39268080119386115Search in Google Scholar

23. Lai, A., Ciccozzi, M., Franzetti, M., Simonetti, F. R., Bozzi, G., Binda, F., . . . Zehender, G. (2014). Local and global spatio-temporal dynamics of HIV-1 subtype F1. J Med Virol, 86(2), 186-192. doi: 10.1002/jmv.2378310.1002/jmv.2378324122963Search in Google Scholar

24. Breslow, N. E. (1987). Statistical methods in cancer research. Volume II - The design and analysis of cohort studies (Vol. no. 82): International Agency for Research on Cancer.Search in Google Scholar

25. Jensen, O. M., Parkin, D. M., MacLennan, R., Muir, C. S., & Skeet, R. G. (1991). Cancer Registration: Principles and Methods (Vol. No. 95): International Agency for Research on Cancer.Search in Google Scholar

26. VOLUMUL I: POPULAŢIA STABILĂ (REZIDENTĂ) – STRUCTURA DEMOGRAFICĂ. (2011). 2015, from http://www.recensamantromania.ro/noutati/volumul/Search in Google Scholar